HEATHER CIOS: Open Payments
NPI 1285330092 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,202 in 159 payments from 19 companies in 2025. Trend: 2023 $1,140 · 2024 $2,475 · 2025 $11,202
Food & beverage: $4,178Speaker / faculty: $3,700Travel & lodging: $2,060Consulting: $1,245Education: $19
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 35 | $6,821 |
| Janssen Biotech, Inc. | 15 | $1,654 |
| ABBVIE INC. | 26 | $469 |
| Madrigal Pharmaceuticals | 11 | $423 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $319 |
| Phathom Pharmaceuticals, Inc. | 8 | $220 |
| Gilead Sciences, Inc. | 5 | $214 |
| Novo Nordisk Inc | 5 | $184 |
| QOL Medical, LLC | 4 | $176 |
| Lilly USA, LLC | 8 | $163 |
Products named: IBSRELA, TREMFYA, REZDIFFRA, VOQUEZNA, ENTYVIO, Wegovy, Sucraid, RINVOQ.
Industry payments across CT — which companies pay providers there.
